The ESMO Advanced Course on ADC Development, Therapeutic Applications, and Research in Thoracic Cancers 2025 will be held in Zurich, Switzerland, on September 24-25, 2025. Co-chaired by experts, the course features an international faculty of leading thoracic oncology and drug development specialists.
It covers the latest advances in antibody-drug conjugates (ADCs), translational research, practical integration of ADCs into clinical care, and future perspectives. The course is highly interactive with lectures, workshops, and discussion seminars, designed for experienced oncologists and specialists. Participants can earn 9 ESMO-MORA category 1 CME points.